Skip to content

Comparison of the effect of Jalinus syrup versus Ondansetron syrup on nausea and vomiting in pregnant women

Comparison of the effect of Jalinus syrup versus Ondansetron syrup on nausea and vomiting in pregnant women: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201709079014N184
Enrollment
120
Registered
2017-09-19
Start date
2017-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting in pregnancy. Vomiting of pregnancy, unspecified

Interventions

Intervention 1: Intervention Group 1: Jalinus syrup consisting of quince fruit, ginger, vinegar and honey, made by Barij Essence Company 5 ml twice a day for 2 weeks. Intervention 2: Intervention grou
Treatment - Drugs
Intervention Group 1: Jalinus syrup consisting of quince fruit, ginger, vinegar and honey, made by Barij Essence Company 5 ml twice a day for 2 weeks.
Intervention group 2: Ondansetron syrup, serotonin receptor antagonist, made by Oxir Pharmaceuticals Company 5 ml twice a day for 2 weeks

Sponsors

Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 18 to 40 years; singleton pregnancy; gestational age of 8 to 9 weeks; first pregnancy; desire for pregnancy; mild to moderate nausea or vomiting (with a minimum and maximum score of 3 to 12). Exclusion criteria: Taking any medication simultaneously (except folic acid); using anti-nausea and vomiting drugs within the last 24 hours; molar pregnancy; symptoms of abortion; alcohol and cigarette smoking; mental disorder; family disputes over the past 6 months; pyelonephritis; thyroid dysfunction; digestive disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Assessing nausea and number of vomiting. Timepoint: before intervention and one week after that. Method of measurement: using PUQE standard questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezoo Shayan

School of Nursing and Midwifery

arezoo.shayan2012@yahoo.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026